Gan & Lee Pharmaceuticals
Gan & Lee Pharmaceuticals (Shanghai Stock Exchange: 603087) is a Chinese biopharmaceutical company founded in 1998, specializing in the research, development, production, and commercialization of recombinant insulin analogs and injection devices for diabetes care, alongside a growing oncology pipeline and medical devices. Its products, including insulin glargine injections and prefilled pen injectors, are marketed across 23 countries with 19 products launched globally and clinical trials running in 10 countries. Gan & Lee does not currently publish a public developer API, SDK, or developer portal; this API Evangelist profile tracks the company's public web presence and domain security posture.
Gan & Lee Pharmaceuticals is profiled on the APIs.io network. Tagged areas include Company, Pharmaceuticals, Diabetes, Insulin, and Oncology.
Gan & Lee Pharmaceuticals’ developer surface includes support and 4 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 1
The organization behind the API